首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2050893

體外診斷（IVD）市場：按產品類型、檢測類型、應用、最終用戶和地區分類

In Vitro Diagnostics Ivd Market, By Product, By Test Type, By Application, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，體外診斷（IVD）市場規模將達到1,352.2億美元，到2033年將達到2,129.1億美元。預計從2026年到2033年，該市場將以6.7%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1352.2億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.70%	2033年市場規模預測：	2129.1億美元

全球體外診斷（IVD）市場涉及對血液、尿液和組織等生物檢體進行疾病檢測。 IVD技術能夠實現疾病的早期發現，從而及時進行臨床干預並改善患者預後。市場成長的促進因素包括老年人口的成長、慢性病和感染疾病盛行率的上升，以及推動更精準的就地檢驗和分子診斷技術發展的進步。然而，一些國家嚴格的新產品核准法規和不利的醫療改革正在阻礙市場成長。

市場動態

全球體外診斷市場正蓬勃發展，其主要促進因素包括：老年人口不斷成長，易患慢性疾病；癌症和糖尿病等文明病發病率上升；以及人們對早期疾病檢測重要性的認知不斷提高。科技進步催生了小型化和攜帶式即時檢測及居家檢測平台，這也是市場成長要素。然而，新診斷產品核准的嚴格監管以及部分地區醫療保險覆蓋範圍的縮小，都對市場成長構成威脅。此外，各國對先進分子診斷檢測的報銷政策不盡相同，這也限制了市場成長。新興經濟體醫療保健支出的成長則帶來了可觀的商業機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球體外診斷市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球體外診斷市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球體外診斷市場分析中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

Siemens Healthineers
Sysmex Corporation
Bio-Rad Laboratories
bioMerieux SA
Becton Dickinson and Company
Danaher Corporation
Abbott Laboratories
F. Hoffmann-la Roche Ltd
QIAGEN NV
Arkray, Inc.
Nittobo Medical Co., Ltd.
Medical & Biological Laboratories Co., Ltd.
Miraca Holdings Inc.
Mizuho Medy Co., Ltd.
Thermo Fischer Scientific Inc
Diasorin
Agilent Technologies, Inc
Grifols SA

第10章分析師觀點

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI195

In Vitro Diagnostics Ivd Market is estimated to be valued at USD 135.22 Bn in 2026 and is expected to reach USD 212.91 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 135.22 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.70%	2033 Value Projection:	USD 212.91 Bn

Global in-vitro diagnostics market involves the testing of biological samples such as blood, urine, tissues, and others for detection of diseases. IVD technologies allow early detection of diseases which helps in timely clinical intervention and improved patient outcomes. The market growth is driven by rising geriatric population, increasing prevalence of chronic and infectious diseases, technological advancements leading to development of more accurate point-of-care and molecular diagnostic tests. However, stringent regulations for new product approvals and unfavorable healthcare reforms in some countries hinders the market growth.

Market Dynamics

Global in-vitro diagnostics market growth is driven by rising geriatric population who are more prone to chronic diseases, increasing incidence of lifestyle diseases such as cancer and diabetes, and growing awareness regarding early disease detection. Technological advancements have led to the development of miniaturized and portable diagnostic platforms for point-of-care and home-based testing, which is another major growth driver. However, stringent regulatory guidelines for approval of new diagnostic products and reduced healthcare coverage in some regions pose threat to the market growth. Furthermore, reimbursement policies for advanced molecular diagnostic tests vary across countries which restrains the market growth. Growing healthcare expenditure in emerging nations offers lucrative opportunities.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global in-vitro diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMerieux S.A., Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray Inc., Nittobo Medical Co. , Medical & Biological Laboratories Co. Ltd., Miraca Holdings Inc., Mizuho Medy Co. Ltd., Thermo Fischer Scientific Inc, Diasorin, Agilent Technologies, Inc, and Grifols SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in-vitro diagnostics market.

Market Segmentation

Product Insights (Revenue, USD Bn, 2021 - 2033)
Reagents & Kits
Instruments
Test Type Insights (Revenue, USD Bn, 2021 - 2033)
Clinical Chemistry
Immunoassay
Hematology
Molecular Diagnostics
Microbiology
Coagulation & Hemostasis
Urinalysis
Others
Application Insights (Revenue, USD Bn, 2021 - 2033)
Infectious Diseases
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune Disorders
Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals & Clinics
Diagnostic Laboratories
Academic & Research Institutes
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Siemens Healthineers
Sysmex Corporation
Bio-Rad Laboratories
bioMerieux S.A.
Becton Dickinson and Company
Danaher Corporation
Abbott Laboratories
F. Hoffmann-la Roche Ltd
QIAGEN N.V.
Arkray Inc.
Nittobo Medical Co. Ltd.
Medical & Biological Laboratories Co. Ltd.
Miraca Holdings Inc.
Mizuho Medy Co. Ltd.
Thermo Fischer Scientific Inc
Diasorin
Agilent Technologies, Inc
Grifols SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Test Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
PEST Analysis

4. Global In-Vitro Diagnostics Market, By Product, 2021 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Reagents & Kits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global In-Vitro Diagnostics Market, By Test Type, 2021 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Clinical Chemistry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Immunoassay
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Hematology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Molecular Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Microbiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Coagulation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global In-Vitro Diagnostics Market, By Application, 2021 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Nephrology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Autoimmune Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global In-Vitro Diagnostics Market, By End User, 2021 - 2033, (US$ Billion)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

8. Global In-Vitro Diagnostics Market, By Region, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioMerieux S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Becton Dickinson, and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
F. Hoffmann-la Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Arkray, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nittobo Medical Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Medical & Biological Laboratories Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Miraca Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mizuho Medy Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fischer Scientific Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Diasorin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Agilent Technologies, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Grifols SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies